The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom

Vaccine - Tập 30 Số 6 - Trang 1225-1234 - 2012
Albert Jan van Hoek1,2, Alessia Melegaro3,2, Nigel Gay3,2, Joke Bilcke4, W. John Edmunds5,1,2
1Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, LondonNW9 5EQ, UK
2Modelling and Economics Unit, Health Protection Agency, London NW9 5EQ, UK
3DONDENA Centre for Research on Social Dynamics, Bocconi University, Via Guglielmo Röntgen n. 1, 20136 Milan, Italy
4Centre for Health Economics Research & Modelling Infectious Diseases University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium
5Centre for the Mathematical Modelling of Infectious Disease, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Centers for Disease Control and Prevention, 1996, Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices, MMWR [Internet], 45, 1

Centers for Disease Control and Prevention, 1999, Prevention of varicella: updated recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR [Internet], 48, 1

Centers for Disease Control and Prevention, 2007, Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices, MMWR, 56, 1

Halloran, 1994, Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States, American Journal of Epidemiology, 140, 81, 10.1093/oxfordjournals.aje.a117238

Brisson, 2000, Modelling the impact of immunization on the epidemiology of varicella zoster virus, Epidemiology and Infection [Internet], 125, 651, 10.1017/S0950268800004714

Brisson, 2002, Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox, Vaccine [Internet], 20, 2500, 10.1016/S0264-410X(02)00180-9

Thomas, 2002, Contacts with varicella or with children and protection against herpes zoster in adults: a case–control study, Lancet [Internet], 360, 678, 10.1016/S0140-6736(02)09837-9

Schuette, 1999, Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles, Bulletin of Mathematical Biology [Internet], 61, 1031, 10.1006/bulm.1999.0126

Brisson, 2003, Epidemiology of varicella–zoster virus in England and Wales, Journal of Medical Virology [Internet], 70, S9, 10.1002/jmv.10313

Brisson, 2000, Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes, Vaccine [Internet], 18, 2775, 10.1016/S0264-410X(00)00100-6

Lopez, 2006, One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?, Pediatrics [Internet], 117, e1070, 10.1542/peds.2005-2085

Michalik, 2008, Primary vaccine failure after 1 dose of varicella vaccine in healthy children, The Journal of Infectious Diseases [Internet], 197, 944, 10.1086/529043

Brisson, 2003, Varicella vaccination in England and Wales: cost-utility analysis, Archives of Disease in Childhood, 88, 862, 10.1136/adc.88.10.862

Thiry, 2003, Economic evaluations of varicella vaccination programmes: a review of the literature, Pharmacoeconomics [Internet], 21, 13, 10.2165/00019053-200321010-00002

Rozenbaum, 2008, Cost-effectiveness of varicella vaccination programs: an update of the literature, Expert Review of Vaccines [Internet], 7, 753, 10.1586/14760584.7.6.753

Guris, 2008, Changing varicella epidemiology in active surveillance sites—United States, 1995–2005, The Journal of Infectious Diseases [Internet], 197, S71, 10.1086/522156

Marin, 2008, Varicella prevention in the United States: a review of successes and challenges, Pediatrics [Internet], 122, e744, 10.1542/peds.2008-0567

Mullooly, 2005, Incidence of herpes zoster, 1997–2002, Epidemiology and Infection [Internet], 133, 245, 10.1017/S095026880400281X

Yih, 2005, The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998–2003, BMC Public Health [Internet], 5, 68, 10.1186/1471-2458-5-68

Jumaan, 2005, Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002, Journal of Infectious Diseases, 191, 2002, 10.1086/430325

Yawn, 2007, A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction, Mayo Clinic Proceedings, Mayo Clinic [Internet], 82, 1341, 10.4065/82.11.1341

Mossong, 2008, Social contacts and mixing patterns relevant to the spread of infectious diseases, PLoS Medicine [Internet], 5, e74, 10.1371/journal.pmed.0050074

Centers for Disease Control and Prevention, 2008, Morbidity and mortality weekly report prevention of herpes zoster recommendations of the advisory prevention of herpes zoster: recommendation of the advisory committee on immunization practices, MMWR, 57, 30

Oxman, 2005, A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults, New England Journal of Medicine [Internet], 352, 2271, 10.1056/NEJMoa051016

van Hoek, 2009, Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales, Vaccine [Internet], 27, 1454, 10.1016/j.vaccine.2008.12.024

van Hoek, 2011, Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England, Vaccine [Internet], 29, 2411, 10.1016/j.vaccine.2011.01.037

2008

2007

Royal College of General Practitioners. Weekly returns service annual report [Internet]. Available from: http://www.rcgp.org.uk/clinical_and_research/rsc/annual_reports.aspx.

Wreghitt, 1996, An analysis of infection control of varicella–zoster virus infections in Addenbrooke's Hospital Cambridge over a 5-year period, 1987–92, Epidemiology and Infection [Internet], 117, 165, 10.1017/S0950268800001278

Chaves, 2008, Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997–2005, The Journal of Infectious Diseases [Internet], 197, S127, 10.1086/522150

Kuter, 2004, Ten year follow-up of healthy children who received one or two injections of varicella vaccine, The Pediatric Infectious Disease Journal [Internet], 23, 132, 10.1097/01.inf.0000109287.97518.67

Gauthier, 2009, Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom, Epidemiology and Infection [Internet], 137, 38, 10.1017/S0950268808000678

Gershon, 2008, Varicella vaccine

Civen, 2009, The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination, The Pediatric Infectious Disease Journal [Internet], 28, 954, 10.1097/INF.0b013e3181a90b16

Briggs, 2006

Leung, 2011, Herpes zoster incidence among insured persons in the United States, 1993–2006: evaluation of impact of varicella vaccination, Clinical Infectious Diseases [Internet], 52, 332, 10.1093/cid/ciq077

Pellissier, 2007, Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults, Vaccine [Internet], 25, 8326, 10.1016/j.vaccine.2007.09.066

Bilcke J, Ogunjimi B, Hulstaert F, Van Damme P, Hens N, Beutels P. Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice? Vaccine [Internet]; (October):13–5 [cited 2011 October 25] available from: http://www.ncbi.nlm.nih.gov/pubmed/21964056, (2011) epub ahead of print.

Office for National Statistics, 2011

Department of Health, 2008